A PE-backed biotech business requires an Interim CFO to lead its finance function through a period of clinical and commercial growth, building team structures and controls within a NetSuite environment.
This 6-9 month interim assignment sits within a PE-backed biotech company that has recently completed a successful clinical trial and is entering a critical operational and commercial development phase. The Interim CFO will take full ownership of the finance function, acting as a senior strategic partner to the CEO, board and investor group while building the infrastructure needed to support the business beyond the assignment.
The role requires a finance leader with prior biotech, life sciences or healthcare experience who can strengthen reporting cadence, manage cash runway and implement robust financial controls within a NetSuite environment. Experience with PE or VC-backed businesses and interim or transformation assignments is highly valued.
- Lead the finance function as the senior finance representative across the organisation
- Partner with the CEO, board and investors on financial strategy, cash runway and scenario planning
- Improve management reporting, KPI visibility and board pack preparation
- Oversee budgeting, forecasting and long-range financial planning
- Strengthen financial controls, governance and reporting infrastructure
- Support clinical and commercial teams with financial insight and decision-making
- Prior experience as a CFO, VP Finance, Finance Director or equivalent senior finance lead
- Background in biotech, life sciences, pharma or healthcare
- Experience operating within a PE or VC-backed business
- Strong skills in cash runway management, forecasting and scenario planning
- Familiarity with NetSuite or equivalent finance systems
- Previous interim, transformation or scale-up experience is an advantage
Harmonic Finance is a Certified B Corp specialising in finance leadership and consulting for the life sciences and biotech sector. The firm partners with PE-backed businesses to support them through growth, operational development and investor engagement phases.
Trusted by fast-growing companies around the world





Not sure where to start? Got a Question?
Your next move is one conversation away.
